Pretomanid

PRETOMANID: US FDA approves new drug for drug-resistant TB

Created: August 17, 2019

United States (US) Food and Drug Administration (FDA) has approved new drug-Pretomanid for treating drug-resistant strain of Tuberculosis (TB). Pretomanid is novel compound developed by New York-based non-profit organisation TB Alliance. It is used alongside two other antibiotics (bedaquiline and ..

Tags:  • • • •

Month: